morphiceptin, n-me-phe(3)- has been researched along with d-ala(2),mephe(4),met(0)-ol-enkephalin in 2 studies
Studies (morphiceptin, n-me-phe(3)-) | Trials (morphiceptin, n-me-phe(3)-) | Recent Studies (post-2010) (morphiceptin, n-me-phe(3)-) | Studies (d-ala(2),mephe(4),met(0)-ol-enkephalin) | Trials (d-ala(2),mephe(4),met(0)-ol-enkephalin) | Recent Studies (post-2010) (d-ala(2),mephe(4),met(0)-ol-enkephalin) |
---|---|---|---|---|---|
95 | 1 | 1 | 293 | 24 | 1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, KJ; Su, YF; Watkins, WD; Wong, CS | 2 |
2 other study(ies) available for morphiceptin, n-me-phe(3)- and d-ala(2),mephe(4),met(0)-ol-enkephalin
Article | Year |
---|---|
Continuous intrathecal opioid treatment abolishes the regulatory effects of magnesium and guanine nucleotides on mu opioid receptor binding in rat spinal membranes.
Topics: Animals; Cell Membrane; D-Ala(2),MePhe(4),Met(0)-ol-enkephalin; Drug Tolerance; Endorphins; Guanylyl Imidodiphosphate; Magnesium; Male; Morphine; Naloxone; Pertussis Toxin; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, mu; Spinal Cord; Virulence Factors, Bordetella | 1992 |
Intrathecal pertussis toxin treatment attenuates opioid antinociception and reduces high-affinity state of opioid receptors.
Topics: Animals; D-Ala(2),MePhe(4),Met(0)-ol-enkephalin; Depression, Chemical; Dose-Response Relationship, Drug; Endorphins; Injections, Spinal; Male; Pertussis Toxin; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Virulence Factors, Bordetella | 1992 |